Cargando…

Added Benefit of Covid-19 Vaccination after Previous Infection

Detalles Bibliográficos
Autor principal:	Klein, Nicola P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Massachusetts Medical Society 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006782/ https://www.ncbi.nlm.nih.gov/pubmed/35353966 http://dx.doi.org/10.1056/NEJMe2201380

Ejemplares similares

Are previous viral infections important for the COVID-19 outcomes?
por: Torres-Flores, Jesus, et al.
Publicado: (2021)

The Potential Benefits of HPV Vaccination in Previously Infected Women
por: Schiller, John T.
Publicado: (2016)

Previous COVID-19 Infection and Antibody Levels After Vaccination
por: Ali, Hamad, et al.
Publicado: (2021)

The benefit of vaccination after previous SARS-CoV-2 infection in the omicron era
por: Boaventura, Viviane S, et al.
Publicado: (2023)

COVID-19 has triggered a new century of vaccination and infection control for the benefit of all mankind
por: Marshall, Barry J
Publicado: (2021)

Co-infections: testing macrolides for added benefit in patients with COVID-19
por: Sterenczak, Katharina Anna, et al.
Publicado: (2020)

Adding to the COVID-19 Educational Script
por: Lenz, Peter H.
Publicado: (2021)

Immune Responses and Breakthrough Infections After COVID-19 Vaccination
por: Kwon, Ki Tae
Publicado: (2023)

COVID-19 Vaccination and Implementation Science: How One Can Benefit the Other
por: Zimmerman, Sheryl, et al.
Publicado: (2021)

Expected Viscosity After COVID-19 Vaccination, Hyperviscosity and Previous COVID-19
por: Joob, Beuy, et al.
Publicado: (2021)

Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection
por: Hall, Victoria, et al.
Publicado: (2022)

mRNA COVID-19 vaccines safe in patients with previous COVID-19 infections
Publicado: (2022)

COVID-19 Infection and Previous BCG Vaccination Coverage in the Ecuadorian Population
por: Garzon-Chavez, Daniel, et al.
Publicado: (2021)

Risks and benefits of vaccines in diabetes
por: Bloomgarden, Zachary
Publicado: (2023)

New machine learning model predicts who may benefit most from COVID-19 vaccination
por: Wedlund, Leia, et al.
Publicado: (2021)

COVID-19 infection and vaccination among children
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Do we need biomarkers to predict the benefit of adding adjuvant taxanes for treatment of breast cancer?
por: Pérez-García, José, et al.
Publicado: (2012)

Immunity after Vaccination against COVID-19
por: Tylicki, Leszek
Publicado: (2023)

Prevalence of Previous COVID-19 Infection, COVID-19 Vaccination Receipt, and Intent to Vaccinate Among the US Workforce
por: Nguyen, Kimberly H., et al.
Publicado: (2022)

Immunogenicity and safety of third-dose mRNA COVID-19 vaccines in healthy adults previously vaccinated with two doses of the ChAdOx1 vaccine
por: Sheng, Wang-Huei, et al.
Publicado: (2023)

Notes on cost benefit of COVID‐19 lockdown
por: Mills, Michael, et al.
Publicado: (2020)

The benefits of pulmonary rehabilitation in patients with COVID-19
por: He, Zhen-feng, et al.
Publicado: (2021)

Myocarditis, Pericarditis and Cardiomyopathy After COVID-19 Vaccination
por: Pepe, Salvatore, et al.
Publicado: (2021)

An Added Benefit of Masks During the COVID-19 Pandemic: Ultraviolet Protection
por: Doyon, Valerie C., et al.
Publicado: (2021)

Reassessing the risks and benefits of COVID-19 precautions in 2023
por: Ollila, Thomas A., et al.
Publicado: (2023)

The interplay between previous infection and mental health condition on antibody response to COVID-19 mRNA vaccination
por: Grignoli, Nicola, et al.
Publicado: (2023)

Short- and long-term noninvasive cardiopulmonary exercise assessment in previously hospitalised COVID-19 patients
por: Singh, Inderjit, et al.
Publicado: (2023)

Should steroids be used for anaphylaxis after the COVID-19 vaccine?
por: Seo, Youngho, et al.
Publicado: (2021)

How likely are COVID-19 interventions to benefit the sickest patients?
por: Perner, Anders, et al.
Publicado: (2020)

Patients’ findings after COVID-19 infection and vaccinations: what to expect from [18F]FDG PET/CT
por: Sollini, Martina, et al.
Publicado: (2021)

Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?
por: Elrashdy, Fatma, et al.
Publicado: (2020)

Remarks on Myocarditis Associated with COVID-19 Infection and Myocarditis Following mRNA COVID-19 Vaccination
por: Frustaci, Andrea
Publicado: (2022)

Protective Immunity of COVID-19 Vaccination with ChAdOx1 nCoV-19 Following Previous SARS-CoV-2 Infection: A Humoral and Cellular Investigation
por: Azamor, Tamiris, et al.
Publicado: (2022)

Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2
por: Havervall, Sebastian, et al.
Publicado: (2021)

Optimizing the benefits of pneumococcal vaccination in the Kingdom of Saudi Arabia
por: Azhar, Esam I., et al.
Publicado: (2016)

The well-known and less well-known benefits of vaccines
por: Michel, Jean-Pierre
Publicado: (2020)

Omicron breakthrough infections in vaccinated or previously infected hamsters
por: Zhou, Jie, et al.
Publicado: (2023)

The COVID-19 vaccination()
por: Casas, Irma, et al.
Publicado: (2021)

Kawasaki Disease During COVID-19 Pandemic in Korea – Data Were Added but Are Needed More
por: Jo, Dae Sun
Publicado: (2022)

“Weighing” the risks and benefits – Thromboprophylaxis challenges in obese COVID-19 patients
por: Rokkam, Venkata Ram Pradeep, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_23pa0g7pgr3m2lb57pab02efl4